INCR
InterCure Ltd.
NASDAQ: INCR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.16
-1.53% today
Updated 2026-09-11
Market cap
$81.02M
P/E ratio
—
P/S ratio
0.65x
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$3 – $8
Volume
0.1M
InterCure Ltd. (INCR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$5.16
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.4B | $0.4B | $0.2B | $0.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -13.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.